arrow
Back
J

John B.A.G. Haanen

Netherlands Cancer Institute

109H-index
930Paper Count
9.8WCitation Count
Published Papers 331
Publication Date
Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy
err2026-06-21
err0
errOAAI
errCato Boreel; Jessie de Ruijter; Olivier van Not; Manja Bloem; Lukas Been; Maureen Aarts; Franchette van den Berkmortel; Christian Blank; Marye Boers-Sonderen; Han Bonenkamp; Jan-Willem de Groot; Dirk Grünhagen; John Haanen; M. Hilde Jalving; Djura Piersma; Bart Rikhof; Marion Stevense-den Boer; Astrid van der Veldt; Lieke Simkens; Michel Wouters
errShare
errSave
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review
err2026-05-27
err0
errOAAI
errMarit Ahrens; John Haanen; Laurence Albiges; Marine Gross Goupil; Ekaterini Boleti; Gwenaelle Gravis; Aude Fléchon; Marc Oliver Grimm; Jens Bedke; Philippe Barthélémy; Daniel Castellano; Begona Mellado; Philipp Ivanyi; Sylvie Rottey; Anne Flörcken; Cristina Suárez; Jose P. Maroto; Viktor Grünwald; Sjoukje Oosting; Jindrich Kopecky
errShare
errSave
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response
err2026-05-25
err0
errOAAI
errMark Schuiveling; Isabella A.J. van Duin; Laurens S. ter Maat; Janneke C. van der Weerd; Rik J. Verheijden; Franchette van den Berkmortel; Christian U. Blank; Gerben E. Breimer; Femke H. Burgers; Marye Boers-Sonderen; Mariette Labots; Jan Willem B. de Groot; John B.A.G. Haanen; Geke A.P. Hospers; Ellen Kapiteijn; Djura Piersma; Lieke Simkens; Hans M. Westgeest; Anne M.R. Schrader; Josien P.W. Pluim
errShare
errSave
Publisher Correction: Clinical development of cancer vaccines
err2026-03-26
err0
PREAI
errJohn B. Haanen; Ton N. M. Schumacher; Jonathan C. Kagan; Edward F. Fritsch; Catherine J. Wu
errShare
errSave
Advances in cell therapy for solid tumours: European perspective and future directions
err2026-03-19
err0
errOAAI
errVictor Moreno; Fiona Thistlethwaite; Ramón Yarza; Willemijn S. Tak; Kok Haw Jonathan Lim; John B.A.G. Haanen
errShare
errSave
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles
err2026-02-26
err0
PREAI
errKedar Kirtane; Michael Kalos; Rocky Billups; Aude G. Chapuis; Vicki Coutinho; Steven A. Feldman; Brian Gastman; John Haanen; Patrick J. Hanley; Priti Hegde; Emily L. Hopewell; Bruce L. Levine; Frederick L. Locke; Marcela V. Maus; Nancy V. Nair; Michael Nathenson; Miguel-Angel Perales; Isabelle Rivière; Devanjan Sikder; Craig Tendler
errShare
errSave
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy
err2026-02-05
err0
errOAAI
errDivya Lenkala; Jessica Kohler; Brian McCarthy; Michael Nelson; Noor A. M. Bakker; Renate de Boer; Emily K. Jackson; Joong Hyuk F. Sheen; Susan Hannes; Ekaterina Esaulova; Kai Stewart; Claudia Gottstein; John Attanasio; Flavian D. Brown; Sebastian Hymson; Shirisha Meda; Maaike van Zon; Saskia Scheij; Rhianne Voogd; Brenda Raud; Ziyan Xu; Jessica S. W. Borgers; Maartje W. Rohaan; Kristen N. Balogh; Asaf Poran; Michael Rooney; Jesse Z. Dong; John R. Srouji; Vikram R. Juneja; Christina M. Arieta; Cynthia M. Nijenhuis; Bastiaan Nuijen; Mark DeMario; Kelledy Manson; Ton N. M. Schumacher; Richard B. Gaynor; John B. Haanen; Joost H. van den Berg; Marit M. van Buuren
errShare
errSave
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial
err2026-01-28
err0
PREAI
errLotte L. Hoeijmakers; Petros Dimitriadis; Steven C. M. A. Wijnen; Irene L. M. Reijers; Marta Lopez-Yurda; Alexander M. Menzies; Annegien Broeks; Sten Cornelissen; Alejandro Torres Acosta; Anja van der Wal; Robyn P. M. Saw; Judith M. Versluis; Winan J. van Houdt; Michel W. Wouters; Jurriaan Romano; Eliza A. Rozeman; Lindsay G. Grijpink-Ongering; Ellen Kapiteijn; Astrid A. M. van der Veldt; Karijn P. M. Suijkerbuijk; Hanna Eriksson; Geke A. P. Hospers; Jos A. van der Hage; Dirk J. Grünhagen; Arjen J. Witkamp; Judith M. Lijnsvelt; Willem M. C. Klop; Charlotte L. Zuur; Annemarie Bruining; Abrahim Al-Mamgani; Thomas E. Pennington; Kerwin F. Shannon; Sydney Ch’ng; Andrew J. Colebatch; Maria Gonzalez; Andrew J. Spillane; John B. A. G. Haanen; Robert V. Rawson; Richard A. Scolyer; Bart A. van de Wiel; Alexander C. J. van Akkooi; Georgina V. Long; Christian U. Blank
errShare
errSave
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials
err2025-12-19
err0
errOAAI
errLeo Bickley; Elisabeth E. Fransen van de Putte; Luna van den Brink; Laura Marandino; Johannes C. van der Mijn; Sofie Wilgenhof; Johannes V. van Thienen; John B.A.G. Haanen; Ekaterini Boleti; Thomas Powles; Patricia J. Zondervan; Niels M. Graafland; Zayd Tippu; Samra Turajlic; Axel Bex
errShare
errSave
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples
errNature
IF48.5
err2025-11-19
err0
errOAAI
errSofía Ibáñez-Molero; Johanna Veldman; Juan Simon Nieto; Joleen J. H. Traets; Austin George; Kelly Hoefakker; Anita Karomi; Rolf Harkes; Bram van den Broek; Su Min Pack; Liselotte Tas; Nils L. Visser; Susan E. van Hal-van Veen; Paula Alóndiga-Mérida; Maartje Alkemade; Iris M. Seignette; Renaud Tissier; Marja Nieuwland; Martijn van Baalen; Joanna Poźniak; Erik Mul; Simon Tol; Sofia Stenqvist; Lisa M. Nilsson; Jonas A. Nilsson; John B. A. G. Haanen; Winan J. van Houdt; Daniel S. Peeper
errShare
errSave
[18F]FDG-PET/CT’s change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial
err2025-10-28
err0
errOAAI
errSabine E. Breukers; Robert D. Crommelin; Laura A. Smit; Jan Paul de Boer; Arash Navran; Winan J. van Houdt; Remco de Bree; Lot A. Devriese; John B. A. G. Haanen; Maurits Wondergem; Charlotte L. Zuur; Wouter V. Vogel
errShare
errSave
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers
errNature
IF48.5
err2025-10-20
err0
PREAI
errPedro B. Tan; Yara L. Verschoor; José G. van den Berg; Sara Balduzzi; Niels F. M. Kok; Marieke E. Ijsselsteijn; Kat Moore; Adham Jurdi; Antony Tin; Paulien Kaptein; Monique E. van Leerdam; John B. A. G. Haanen; Emile E. Voest; Noel F. C. C. de Miranda; Ton N. Schumacher; Lodewyk F. A. Wessels; Myriam Chalabi
errShare
errSave
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial
err2025-10-08
err0
errOAAI
errSabine E. Breukers; Joleen J. H. Traets; Stan W. van Dijk; Mercedes Machuca Ostos; Itske Fraterman; Robert D. Crommelin; Hedda van der Hulst; Xiaohang Qiao; Thomas Boere; Lonneke V. van de Poll-Franse; Valesca Retèl; Vincent van der Noort; Joris L. Vos; Alexandra G. L. Toppenberg; Martijn van der Heijden; Francesco Missale; Fons Balm; Michiel van den Brekel; Richard Dirven; M. Baris Karakullukcu; Luc Karssemakers; W. Martin C. Klop; Peter J.F.M Lohuis; Willem H. Schreuder; Ludi E. Smeele; Lilly-Ann van der Velden; Elsemieke Plasmeijer; Laura A. Smit; Jan Paul de Boer; Arash Navran; Bram Westerink; Petra K. de Koekkoek-Doll; Jonas Castelijns; Maurits Wondergem; Wouter V. Vogel; Anke Kuijpers; Winan J. van Houdt; Suzanne Onderwater; Esther Maas-Bannink; Sten Cornelissen; Annegien Broeks; Bernard M. Tijink; Lot A. Devriese; Remco de Bree; Christian U. Blank; Ton N. Schumacher; Daniela S. Thommen; John B.A.G. Haanen; Charlotte L. Zuur
errShare
errSave
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study
err2025-10-07
err0
errOAAI
errJessica S.W. Borgers; Douglas B. Johnson; Elisabeth Livingstone; Dirk Schadendorf; Elizabeth I. Buchbinder; Lauren E. Haydu; Laura Gohil; William A. Robinson; Inderjit Mehmi; Omid Hamid; Michelle Ferreira; April K.S. Salama; Florentia Dimitriou; Matteo S. Carlino; Georgina V. Long; Paolo A. Ascierto; Ester Simeone; Yana G. Najjar; Geke A.P. Hospers; Jacob Choi; Sunandana Chandra; Jeffrey D. Wayne; Carlos I.R. García; Wen Xu; Céleste Lebbé; Laetitia Da-Meda; Victoria Atkinson; Meredith Mckean; Andrea Forschner; Elliot A. Asare; Antonios Daletzakis; Jolyn S. Taylor; Frédéric Amant; Katy K. Tsai; Zeynep Eroglu; John B.A.G. Haanen; Isabella C. Glitza de Oliva
errShare
errSave
Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
err2025-08-04
err0
errOAAI
errJessica S. W. Borgers; Divya Lenkala; Victoria Kohler; Emily K. Jackson; Matthijs D. Linssen; Sebastian Hymson; Brian McCarthy; Elizabeth O’Reilly Cosgrove; Kristen N. Balogh; Ekaterina Esaulova; Kimberly Starr; Yvonne Ware; Sebastian Klobuch; Tracey Sciuto; Xi Chen; Gauri Mahimkar; Joong Hyuk F. Sheen; Suchitra Ramesh; Sofie Wilgenhof; Johannes V. van Thienen; Karina C. Scheiner; Inge Jedema; Michael Rooney; Jesse Z. Dong; John R. Srouji; Vikram R. Juneja; Christina M. Arieta; Bastiaan Nuijen; Claudia Gottstein; Olivia C. Finney; Kelledy Manson; Cynthia M. Nijenhuis; Richard B. Gaynor; Mark DeMario; John B. Haanen; Marit M. van Buuren
errShare
errSave
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors
err2025-07-22
err0
PREAI
errFemke H. Burgers; Johannes C. K. van der Mijn; Tom T. P. Seijkens; Inge Jedema; Axel Bex; John B. A. G. Haanen
errShare
errSave
The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma
err2025-07-13
err0
PREAI
errMees D. Egeler; Sebastian Klobuch; Willemijn S. Tak; Maartje W. Rohaan; Troels H. Borch; Inge. M. Noringriis; Renaud Tissier; Minke W. Lucas; Winan van Houdt; Alexander C.J. van Akkooi; Inge Jedema; Marco Donia; Christian U. Blank; Inge Marie Svane; John B.A.G. Haanen; Lonneke V. van de Poll-Franse
errShare
errSave
Health-Related Quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared to ipilimumab in a randomized phase 3 trial
err2025-06-18
err0
PREAI
errR.M.T. ten Ham; M.W. Rohaan; M. Egeler; R. Menezes; T. Holz Borch; R. Kessels; I. Jedema; B. Nuijen; C.M. Nijenhuis; L.V. van de Poll-Franse; M.H. Geukes Foppen; M. Lindenberg; I. Mansfield Noringriis; T.J. Monberg; M. Donia; W. van Harten; I.M. Svane; J.B.A.G. Haanen; V.P. Retèl
errShare
errSave
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial
err2025-06-01
err0
PREAI
errHoeijmakers, L. L.; Rozeman, E. A.; Lopez-Yurda, M.; Grijpink-Ongering, L. G.; Heeres, B. C.; van de Wiel, B. A.; Flohil, C.; Sari, A.; Heijmink, S. W. T. P. J.; van den Broek, D.; Broeks, A.; de Groot, J. W. B.; Vollebergh, M. A.; Wilgenhof, S.; van Thienen, J. V.; Haanen, J. B. A. G.; Blank, C. U.
errShare
errSave